Archive for the ‘Medical Devices’ Category

Anthony
LaFauce

mHealth is the Future

Monday, August 16th, 2010

welldocWellDoc, a company focused on developing next generation medical tools, announced that the FDA has approved its DiabetesManager System. I can hear you now, “what’s the big deal? There are plenty of those on the market already.” The key to this new system is that it delivers real-time monitoring results to a person’s mobile phone.

Again, is it really that great of a tool? The DiabetesManager System also links directly to the patient’s caregiver via the patient’s phone and can provide automated health updates. HIPA you say? Well the company’s press release says nothing about privacy issues, but because this is an ‘opt in’ program that communicates directly with a patient’s caregiver, the information passed is no different than a patient calling his or her caregiver.

After a quick read-through of the WellDoc’s site, I was able to read that the information captured is held in a highly secure database that only allows for approved member access. I understand the need for HIPA, but on the other hand I understand the need to provide healthcare information on the go. (more...)

Tags: , ,

 
Innovation

Technology Tuesday: How Changes to the 510(k) Process Impact Us All

Tuesday, March 23rd, 2010

If you work in health care or as a communications partner to a medical device manufacturer, chances are very high that you are familiar with the 510(k) process. Yet, the average patient who benefits from the medical technology approved through this process each year may know very little about it.    

All medical devices must go through the Food and Drug Administration (FDA) for approval. The Medical Device Amendments Act of 1976 established a regulatory framework that would classify all devices based on their complexity and the degree of risk to the public. This legislation made it easier for manufacturers to bring simpler products to market like tongue depressors, elastic bandages and gauzes. Other devices like medical imaging equipment, endoscopes and dialysis catheters, for example, are subject to the FDA's 510(k) or premarket clearance of devices that examines whether a device is "substantially equivalent" to a predicate or existing device.  The FDA also determines whether additional clinical testing is needed before the device can be sold in the U.S. While originally designed as the exception to the approval rule, the 510(k) process has now become the norm. In fact, approximately 90 percent of medical devices in the U.S. have been evaluated by the FDA through this process.

Today with the majority of devices going through this process, the 510(k) is facing scrutiny from within the FDA itself, advocate groups and lawmakers on Capitol Hill who are questioning whether this process, as it currently stands, still provides safe and effective devices to consumers. (more...)

Tags: , ,

 
Shellie
Byrum

Device Companies Slow to Join Digital Revolution

Monday, February 1st, 2010

Medical device companies may be their own worst enemy when it comes to social media.

Since I started working in this field, I've noticed that device companies in general are behind in joining the digital revolution, especially when compared to other FDA-regulated companies in the pharmaceutical and biotechnology fields. In fact, a survey released in December showed that only 16 percent of FDA-regulated device companies reported using social media to connect with customers or prospects. (more...)